financetom
Business
financetom
/
Business
/
Procter & Gamble Warns $800M Rise In Tariff Costs, Picks New CEO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Procter & Gamble Warns $800M Rise In Tariff Costs, Picks New CEO
Jul 29, 2025 9:16 AM

Procter & Gamble Company ( PG ) , maker of popular brands such as Gillette, Tide, Pampers and Crest, released its fourth-quarter earnings report on Tuesday and issued the fiscal 2026 outlook.

Gillette maker reported fourth-quarter adjusted earnings per share of $1.48, beating the analyst consensus estimate of $1.42.

Quarterly sales of $20.889 billion (+2% year over year) outpaced the street view of $20.765 billion.

Organic sales, which exclude the impacts of foreign exchange and acquisitions and divestitures, also increased 2%.

Also Read: Stock Market Today: US Futures Rise Following S&P 500's 6-Days Of Record Close—Boeing, P&G, Starbucks Earnings In Focus

Higher pricing and favorable mix impacts contributed a 1% increase in sales growth.

Organic sales grew across all segments, with Beauty, Grooming, Fabric & Home Care, and Baby, Feminine & Family Care each increasing by 1% and Health Care rising by 2% year over year.

Reported gross margin for the quarter under review decreased 50 basis points to 49.1% year over year.

Core gross margin for the quarter decreased 70 basis points compared to the same quarter a year ago, or 50 basis points on a currency-neutral basis. 

Operating margin jumped 190 basis points to 20.8% in the quarter under review.

In June 2025, the company announced a portfolio and productivity plan aimed at improving its cost structure and competitiveness.

As part of the plan, it expects to incur $1 to $1.6 billion in non-core restructuring costs over two years, including reducing up to 7,000 non-manufacturing overhead roles by the end of fiscal 2027.

Half of the costs are expected to be incurred by the end of fiscal 2026, with the rest in fiscal 2027. The company exited the quarter with cash and equivalents worth $9.482 billion.

Outlook

Procter & Gamble ( PG ) expects fiscal 2026 adjusted EPS in the range of $6.83 to $7.09, compared with the $6.99 consensus estimate.

The company projects FY2026 sales between $85.126 billion and $88.498 billion, versus the estimated $86.492 billion. GAAP EPS is forecasted between $6.71 and $7.09, compared with the $6.95 estimate.

The company estimates a headwind of around $200 million after-tax from unfavorable commodity costs and a net headwind of roughly $250 million after-tax from modestly higher net interest expense.

Procter & Gamble ( PG ) sees a headwind of 39 cents per share for fiscal 2026, or a 6% drag on core EPS growth.

The company's outlook includes around $1 billion before-tax, or approximately $800 million after-tax, in higher costs from tariffs. 

"In fiscal 2026, we expect to deliver another year of organic sales growth, Core EPS growth and strong adjusted free cash flow productivity," said Chief Executive Officer Jon Moeller. 

Management Transition

In a separate release, the firm announced that Shailesh Jejurikar, currently Chief Operating Officer, will succeed Jon Moeller as Procter & Gamble's ( PG ) President and Chief Executive Officer, effective January 1, 2026.

The board has also nominated Jejurikar to stand for election as a Director at the annual shareholder meeting in October 2025.

On January 1, 2026, Jon Moeller will become Procter & Gamble's ( PG ) Executive Chairman.

Price Action: PG shares are trading higher by 0.10% to $157.27 at last check Tuesday.

Read Next:

Opendoor Skyrockets 314% In A Month Amid Meme Stock Mania: Hedge Fund Manager Who Reaped Windfall Gains Says ‘I'm Not Here To Pump Up A Stock'

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved